Transudate vs. Exudate: How Doctors Tell Them Apart

A transudate is fluid that leaks out of blood vessels because of pressure imbalances, while an exudate is fluid that escapes because something has damaged or inflamed the vessel walls themselves. That single distinction drives nearly every decision doctors make when fluid shows up where it should not, most commonly in the space around the lungs. The difference sounds straightforward, but identifying which type you are dealing with in practice requires lab testing, and the standard tests have well-known blind spots that trip up clinicians regularly.

How Each Type of Fluid Forms

Your blood vessels constantly push fluid outward through their walls and pull it back in. The push comes from the blood pressure inside the vessel (hydrostatic pressure), and the pull comes from proteins in the blood that act like tiny sponges, drawing water back in (oncotic pressure). Under normal conditions, these forces roughly balance out, and only a tiny amount of fluid filters into the pleural space around the lungs before getting reabsorbed.

A transudate forms when that balance tips. If blood pressure climbs too high on one side or protein levels drop too low on the other, more fluid filters out than gets pulled back. The vessel walls stay intact; they are not injured or inflamed. They are simply overwhelmed by the physics of the situation.¹ The result is a thin, watery, low-protein fluid.²

An exudate forms when the vessel walls themselves are compromised. Infection, cancer, autoimmune inflammation, or injury can make the walls leaky, allowing not just water but proteins, enzymes, cells, and debris to spill into the surrounding space. Oxidative stress, inflammation, and the activation of cell-death pathways are the main drivers of this excessive permeability.³ The resulting fluid is thick, protein-rich, and often cloudy or colored.

What Causes Each Type

The cause list for transudates is short, and one condition dominates. Congestive heart failure is by far the most common cause, because a failing heart backs up blood pressure into the pulmonary circulation and tips the hydrostatic balance.⁴ Liver cirrhosis with ascites, nephrotic syndrome (where protein pours out through the kidneys, dropping blood oncotic pressure), and pulmonary embolism round out the usual suspects.

Exudates have a much longer list of causes because anything that inflames or damages tissue can trigger one. The most common culprits are pneumonia, cancer, and tuberculosis. Autoimmune diseases like rheumatoid arthritis and lupus cause exudative effusions as well. Certain medications can produce pleural disease through mechanisms ranging from allergic reactions to direct toxic damage to chemical-induced inflammation.⁵ The clinical stakes differ accordingly: a transudate usually means you treat the underlying systemic problem (strengthen the heart, address the liver disease), while an exudate often demands you figure out exactly what is attacking the pleura and treat that directly.

How Doctors Tell Them Apart

The standard tool has been the same for over four decades: Light’s criteria. After a sample of pleural fluid is drawn, the lab measures the protein and lactate dehydrogenase (LDH, an enzyme released when cells are damaged) in both the fluid and the patient’s blood. The fluid is classified as an exudate if it meets any one of three cutoffs: a fluid-to-serum protein ratio above 0.5, a fluid-to-serum LDH ratio above 0.6, or a fluid LDH level above two-thirds of the upper limit of normal for serum. Meeting even one of those thresholds is enough.

Light’s criteria are very good at catching exudates. Across studies, their accuracy for correctly identifying exudative effusions runs around 95 percent or higher.⁶ One study comparing them with alternative methods found accuracy reaching about 98 percent for exudate identification.⁷ Multiple proposed modifications and alternatives have been tested over the years, but none have managed to consistently outperform the originals by a meaningful margin.

The criteria are deliberately weighted to err on the side of calling something an exudate, because missing an exudate (and therefore missing an infection or malignancy) is more dangerous than overcalling one. That asymmetry has a well-known cost: roughly a quarter of true transudates get mislabeled as exudates.

The Diuretic Problem

That 25 percent misclassification rate is not random. It clusters heavily among heart failure patients on diuretics, and the reason is mechanical. Diuretics pull water out of the body, including from pleural fluid. As water leaves, everything dissolved in the fluid becomes more concentrated. Protein levels climb, LDH levels climb, and the fluid starts looking like an exudate on paper even though the vessel walls were never inflamed.

Research tracking heart failure patients undergoing diuresis at 48-hour intervals showed that pleural fluid protein rose by about 43 percent and LDH rose by about 67 percent over the course of treatment, progressively pushing more patients past the exudate cutoffs.⁸ Another study confirmed that the concentrations of nearly every commonly measured biochemical component in pleural fluid increase significantly during diuretic therapy.⁹

When clinicians suspect they are dealing with a “pseudoexudate” created by diuretics, the main rescue test is the serum-to-pleural-fluid albumin gradient. If that gradient remains above 1.2 g/dL, the effusion is likely still a transudate despite meeting Light’s exudate thresholds. That gradient tends to hold up because diuretics concentrate albumin in both compartments more or less proportionally, so the gap between them stays stable even as absolute levels rise.

Lab Variability Between Hospitals

There is a less well-known source of error that rarely gets discussed outside pathology circles. The analytical platforms (the actual machines) used in different hospital labs do not always produce the same LDH and protein values on the same sample. A study analyzing 83 paired serum and pleural fluid samples across different lab platforms found only 82 percent concordance in transudate-versus-exudate classification when the fluid protein fell in the diagnostically ambiguous range of 25 to 35 g/L. The LDH ratio and protein ratio varied significantly depending on which platform ran the test.¹⁰ In borderline cases, your classification could literally change depending on which hospital lab processes your sample. This is one reason experienced clinicians treat the transudate-exudate boundary as a guide rather than a verdict, especially when the numbers fall close to the cutoffs.

What Happens After Classification

Once the fluid is classified, the workup branches. Transudates generally do not require further pleural investigation; the focus shifts to managing the underlying condition. Exudates, however, open a wide diagnostic investigation because the cause could be anything from bacterial infection to cancer to tuberculosis.

Cell Counts and Differential

Looking at which types of white blood cells dominate the fluid provides direction. A neutrophil-rich effusion strongly suggests an infectious cause, with a positive likelihood ratio above 20 for infection when neutrophils predominate. A lymphocyte-predominant pattern is classically associated with malignancy and tuberculosis, though its sensitivity for cancer is only about 36 percent, meaning many malignant effusions do not show it.¹¹ An interesting wrinkle is that about 43 percent of eosinophil-rich effusions in one large analysis turned out to be malignant, complicating the old teaching that eosinophils in pleural fluid are reassuring.

How those cells get counted also matters. Automated analyzers and manual microscopy do not always agree. When automated analysis shows a polymorphonuclear cell percentage above 50 percent or below 30 percent, the call lines up reliably with the manual result. In the middle zone, though, agreement breaks down, leaving the dominant cell type ambiguous.¹²

pH and Glucose

Pleural fluid pH and glucose levels help gauge severity, particularly in infection. Bacteria consuming glucose and producing acid drive both values down. A low pH (generally below 7.2) in an infected effusion often pushes the decision toward drainage rather than antibiotics alone. A large multi-center study of nearly 3,000 cases found that pH alone captured about 95 percent of infection-related effusions that had either pH or glucose below the diagnostic cutoff, suggesting that for most purposes, pH is the more reliable of the two markers.¹³

Beyond the Pleura

The transudate-exudate framework is most firmly established for pleural effusions, but the same logic applies wherever abnormal fluid accumulates. Pericardial effusions (fluid around the heart) can also be classified this way, and Light’s criteria perform well in that context too. One study found the criteria had 98 percent sensitivity for identifying pericardial exudates when applied to fluid drawn from the pericardial sac.¹⁴ Peritoneal fluid (ascites) uses a different classification system, the serum-ascites albumin gradient (SAAG), because the transudative causes of ascites (chiefly portal hypertension from liver disease) are so common that a simpler, more direct test won out in practice.

Lipid Effusions and When the Fluid Looks Like Milk

Some effusions do not fit neatly into the standard framework because their defining feature is lipid content rather than protein or LDH. Chylothorax occurs when the thoracic duct (the main lymphatic highway in the chest) is disrupted or blocked, leaking lymphatic fluid rich in triglycerides into the pleural space. The fluid is often milky white. A triglyceride level above 110 mg/dL with a cholesterol level below 200 mg/dL is diagnostic, and finding chylomicrons in the fluid confirms it.¹⁵

Cholesterol pleural effusion is a separate entity that can look similar but has a completely different backstory. It develops in long-standing, trapped effusions where cell membranes break down and release cholesterol. The two forms of lipid effusion share a milky appearance but differ in their causes, management, and prognosis.¹⁶ The lesson for the general framework is that a milky effusion is its own diagnostic category; trying to force it into the transudate-exudate box before testing lipids can lead you astray.

Testing for Tuberculosis

In regions where tuberculosis is common, exudative pleural effusions with a lymphocyte-predominant pattern automatically raise suspicion for TB pleuritis. Two biomarkers help narrow it down. Adenosine deaminase (ADA) is the more widely available test and achieves roughly 88 percent sensitivity and 91 percent specificity for pleural TB. Unstimulated interferon-gamma performs slightly better, with about 91 percent sensitivity and 96 percent specificity. A meta-analysis comparing the two found interferon-gamma had consistently greater diagnostic accuracy across the full range of clinical settings, though ADA remains the workhorse in many parts of the world because of cost and availability.¹⁷

Getting the Sample Safely

None of these lab tests matter if you cannot safely obtain the fluid. Thoracentesis, the procedure where a needle drains fluid from the pleural space, has historically carried a real risk of puncturing the lung and causing a pneumothorax (collapsed lung). Older data put the rate as high as 20 to 39 percent without imaging guidance. Ultrasound guidance has transformed the safety profile. A study of 445 thoracentesis procedures in cancer patients found the pneumothorax rate dropped from about 9 percent without ultrasound to under 1 percent with it, and every case requiring a chest tube had been performed without guidance.¹⁸ The Society of Hospital Medicine now recommends ultrasound guidance for all thoracenteses, including in mechanically ventilated patients.¹⁹

Another older concern was bleeding risk in patients on blood thinners. More recent evidence suggests that thoracentesis can be performed safely in many patients with coagulopathy or on anticoagulant therapy without first correcting the bleeding parameters, though this remains a case-by-case judgment.²⁰ Re-expansion pulmonary edema, where the lung becomes waterlogged after being re-inflated too quickly following large-volume drainage, is rare but serious and is thought to result partly from excessively negative pressure generated during rapid fluid removal.

Pleural Effusions in Children

Light’s criteria were developed and validated in adults, and their application in children is less well established. One reason is that pediatric pleural effusions are uncommon enough that large validation studies are scarce. A single-institution study found that Light’s criteria were used infrequently in hospitalized children with effusions of unknown cause, and practice varied widely among clinical teams. When the criteria were applied, they often helped establish a diagnosis or change management and appeared to reduce the chance of the effusion recurring within 30 days.²¹ The diuretic-related misclassification problem applies in pediatric patients as well, and the albumin gradient workaround remains useful: in children on diuretics, the serum-to-pleural-fluid albumin gradient typically stays above 12 g/L in true transudates even when Light’s criteria suggest otherwise.²²

How Veterinarians Use the Same Framework

Veterinary medicine has traditionally classified effusions in dogs and cats using a different system based on total protein concentration and total nucleated cell count in the fluid itself, without comparing to serum values. This older scheme creates a three-tier system (transudate, modified transudate, exudate) rather than the binary split used in human medicine. It turns out this approach does not work very well. A study in dogs compared the traditional veterinary classification with a simplified version of Light’s criteria and found striking results: the simplified Light’s criteria correctly identified exudates with 98 percent accuracy, while the traditional veterinary method managed only 57 percent.²³ The traditional system particularly struggled with transudates caused by elevated hydrostatic pressure, misclassifying two-thirds of them.

In cats, similar work has been done to evaluate classification methods for pleural effusions, recognizing that the underlying pathophysiology of transudates (decreased oncotic pressure or elevated hydrostatic pressure) and exudates (increased capillary permeability) parallels what happens in people.²⁴ LDH appears to be useful across species as well: one study confirmed that LDH activity was significantly higher in exudates than transudates in both dogs and cats, and that an effusion-to-serum LDH ratio below 0.5 reliably identified transudates.²⁵ The irony is that a diagnostic framework designed for humans in the 1970s may end up replacing a veterinary-specific scheme that has been in use for decades, simply because it performs better.